We exhibited at WHX Tech 2025, presenting our vision of transforming cancer care with genetically and technically diverse data combined with robust AI models. In Dubai, a city that embodies global diversity, we demonstrated how our mission to turn complex data into diagnostics that work for everyone resonates with healthcare leaders, innovators, and patients alike.
Our Keynote: Tackling the Remaining84
Our CEO Dr. Manasi A-Ratnaparkhe delivered a powerful keynote about the Remaining84 problem at the center of the conversation, drawing attention to the 84 percent of the world’s populations that remain underrepresented in medical AI. She stressed that equity in healthcare is not optional. Without diverse data, diagnostics risk excluding the majority of world. PAICON’s answer is to build a multinational, multimodal cancer data lake and apply ISO 13485–compliant AI models that integrate diversity at every step. This approach ensures diagnostics that are accurate, unbiased, and truly global in their relevance.
Conversations that Matter
Throughout the three days of WHX Tech, our booth became a focal point of engagement. More than 50 visitors joined us, including patients, innovators, investors, and representatives from the Dubai Health Authority. These interactions reaffirmed the urgency of inclusive diagnostics and the growing recognition that diverse data is the foundation for trustworthy AI in oncology. Dubai’s unique role as a hub where different cultures and perspectives meet made these conversations especially powerful, reflecting the very principle PAICON stands for: building solutions that include everyone.
Looking Ahead
The energy and interest we experienced at WHX Tech 2025 strengthen our commitment to scale our data lake, expand our collaborations with healthcare providers and pharma, and accelerate the adoption of equitable AI diagnostics worldwide. PAICON will continue to lead with diversity, innovation, and collaboration because transforming cancer care for everyone begins with including everyone.
